NCT03804359 - Personalized Medicine for Membranous Nephropathy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

September 30, 2024

Study Completion Date

November 5, 2024

Conditions

Idiopathic Membranous Nephropathy

Interventions

DRUG

Rituximab

"In the personalized arm, the patient will be treated in function of the CysR activity result during the inclusion visit."

Trial Locations (19)

13005

AP-HM, Marseille

14033

CHU de Caen, Caen

25000

CHU Besançon, Besançon

29069

Hôpital universitaire La Cavale Blanche, Brest

30029

CHU Carémeau, Nîmes

31059

CHU de Toulouse, Toulouse

34295

CHRU de Montpellier, Montpellier

37044

CHU de Tours, Tours

44093

CHU de NANTES, Nantes

51092

Hôpital de la maison blanche, Reims

59037

CHRU de LILLE, Lille

63000

CHU Gabriel Montpied, Clermont-Ferrand

67091

CHU de Strasbourg, Strasbourg

69437

CHU de LYON NORD, Lyon

75015

Hôpital Necker, Paris

80800

CHU D'amiens Hôpital Sud, Amiens

94010

CHU Henri Mondor, Créteil

94275

Le Kremlin Bicêtre, Paris

06000

Dr Barbara SEITZ-POLSKI, Nice

All Listed Sponsors

lead

Centre Hospitalier Universitaire de Nice

OTHER